
Nippon India Pharma Fund(G)
- Equity
- Sector Funds
- Very High Risk
Fund Overview
- Assets Under Management (AUM)
- ₹8,635.75 Cr
- Expense Ratio
- 1.52%
- Riskometer
- Very High
- Category
- Sector Funds
- Asset Type
- Equity
- Benchmark
- BSE SENSEX - TRI
- SIP
- Available
- Switch
- Available
- Inception Date
- 30 Mar 2006
- ISIN
- INF204K01968
- Scheme Code
- PHGP
- Fund Scheme ID
- 1946
Thinking of investing in mutual funds?
Discover a simpler way to begin investing with Indipe.
Performance & Returns
Calculate SIP ReturnsReturns by period
| Period | Trailing Return | Absolute Return | Annualised Return | CAGR |
|---|---|---|---|---|
| 1 Month | -0.20% | 0.18% | -2.32% | 2.91% |
| 3 Months | 7.50% | 7.18% | 29.75% | 36.89% |
| 6 Months | 12.81% | 12.01% | 25.41% | 24.90% |
| 1 Year | 10.69% | 11.41% | 10.69% | 11.65% |
| 3 Years | 18.29% | 63.82% | 21.85% | 18.49% |
| 5 Years | 12.52% | 82.47% | 16.07% | 12.65% |
| Since Inception | 19.92% | 5620.41% | 251.87% | 19.95% |
Past performance is not indicative of future returns.
Portfolio
Asset Allocation
100.00%
- Domestic Equities97.92%
- Cash & Cash Equivalents and Net Assets2.08%
Top Sectors
- Healthcare92.45%
- Retailing3.68%
- Miscellaneous2.16%
- Business Services1.79%
Holdings
Overview of fund allocations across sectors and securities
Healthcare
Value
₹7,983.75 Cr
Weightage
92.45%
Retailing
Value
₹317.80 Cr
Weightage
3.68%
Miscellaneous
Value
₹186.53 Cr
Weightage
2.16%
Business Services
Value
₹154.58 Cr
Weightage
1.79%
About
Fund Manager(s)
Mr. Sailesh Raj Bhan
Launch Date
30 Mar 2006
Benchmark
BSE SENSEX - TRI
Objective
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
RISKOMETER
The riskometer indicates the level of risk associated with the fund based on historical data and portfolio composition.
Exit Load, Stamp Duty and Tax Implication
- Exit load
- 1% on or before 1M, Nil after 1M
- Stamp duty on investment: 0.005% (from July 1st, 2020)
- from July 1st 2020
- Tax implication
- --